Full text is available at the source.
Abstract
GLP1-RAs, particularly liraglutide (1.8-3 mg), significantly reduced mean BMI and body weight percentage at six months in a meta-analysis of 130 patients.
- Adjunctive treatments like GLP1-RAs are being explored to improve weight loss after bariatric surgery.
- The meta-analysis included data from three randomized controlled trials.
- Significant reductions in mean BMI and body weight percentage were observed at six months with GLP1-RA therapy.
- Future research is needed to evaluate newer GLP1-RAs with weekly dosing and longer follow-up periods.
Simplified